Treatment of MGMT promoter unmethylated glioblastoma with PD-1 inhibitor combined with anti-angiogenesis and epidermal growth factor receptor tyrosine kinase inhibitor: a case report.

Wang, Zheng; Du, Fangfang; Ren, Yi; Jiang, Wei

Wang, Zheng; Du, Fangfang; Ren, Yi; Jiang, Wei.

Afiliação

Wang Z; Department of Radiation Oncology, Tianjin Huanhu Hospital, Tianjin, China.
Du F; Department of Radiation Oncology, Tianjin Huanhu Hospital, Tianjin, China.
Ren Y; Department of Radiation Oncology, Tianjin Huanhu Hospital, Tianjin, China.
Jiang W; Department of Radiation Oncology, Tianjin Huanhu Hospital, Tianjin, China.

Ann Transl Med ; 9(19): 1508, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34805370

Palavras-chave

Oxitinib; anlotinib; carelizumab; case report; glioblastoma (GBM)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google